BG-60366
BG-60366-101
Phase 1 small_molecule terminated
Quick answer
BG-60366 for Non-Small Cell Lung Cancer is a Phase 1 program (small_molecule) at BeOne Medicines with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BeOne Medicines
- Indication
- Non-Small Cell Lung Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated